Results: 476 medical oncology positions comprising 234 FTE MOs were identified. Of the 150 medical oncology practices, 117 (78%) were in metropolitan locations and 33 (22%) were in rural locations. The average number of new patients seen per FTE MO was 270 patients (ranging by state from 191 to 343). The demand for FTE MOs was estimated at 326 to 391 in 2009 and 361 to 432 in 2014. The shortfall of FTE MOs was estimated at 92 to 157 in 2009 and 84 to 156 in 2014. The chemotherapy utilisation rate was 19%.
Conclusions: The current shortage of MOs is expected to persist in the future. National strategies are needed to increase the capacity of the medical oncology workforce and the chemotherapy utilisation rate.
- 1. Systemic Therapy Task Force. STTF Report. Ontario: Cancer Care Ontario, 2000. https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=14436 (accessed Nov 2011).
- 2. Erikson C, Salsberg E, Forte G, et al. Future supply and demand for oncologists: challenges to assuring access to oncology services. J Oncol Pract 2007; 3: 79-86.
- 3. Hortobagyi GN; American Society of Clinical Oncology. A shortage of oncologists? The American Society of Clinical Oncology workforce study. J Clin Oncol 2007; 25: 1468-1469.
- 4. Warren JL, Mariotto AB, Meekins A, et al. Current and future utilization of services from medical oncologists. J Clin Oncol 2008; 26: 3242-3247.
- 5. Barrett J. Building for the future. Clin Oncol (R Coll Radiol) 2009; 21: 573-574.
- 6. Australian Medical Workforce Advisory Committee. The specialist medical and haematological oncology workforce in Australia: supply, requirements and projections, 2001–2011. Sydney: AMWAC, 2001. http://www.ahwo. gov.au/publications.asp (accessed Nov 2011).
- 7. Association of American Medical Colleges Center for Workforce Studies. Forecasting the supply of and demand for oncologists: a report to the American Society of Clinical Oncology. Alexandria, Va: ASCO, 2007. http://www.asco. org/ASCO/Downloads/Cancer%20Research/Oncology%20Workforce%20Report%20FINAL.pdf (accessed Nov 2011).
- 8. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program. SEER*Rx Interactive Antineoplastic Drugs Database, version 1.5.0. Bethesda, Md: NCI, 2010. http://www.seer. cancer.gov/tools/seerrx/ (accessed Nov 2011).
- 9. Australian Institute of Health and Welfare. Rural, Remote and Metropolitan Area (RRMA) classification. Canberra: AIHW, 2011. http://www. aihw.gov.au/rural-health-rrma-classification/ (accessed Dec 2011).
- 10. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2010: an overview. Canberra: AIHW, 2010. (AIHW Cat. No. CAN 56; Cancer Series No. 60.) http://www.aihw.gov.au/publication-detail/?id=6442472459 (accessed Dec 2011).
- 11. Australian Bureau of Statistics. Australian demographic statistics, Jun 2009. Canberra: ABS, 2009. http://www.abs.gov.au/AUSSTATS/abs@.nsf/allprimarymainfeatures/EB76EA379A 44E842CA2576F0001C70C9?opendocument (accessed Dec 2011).
- 12. Ng WL, Jacob S, Delaney G, et al. Optimal chemotherapy utilization rate in cancer care: setting an evidence-based benchmark for quality improvement. J Clin Oncol 2010; 28 (15 Suppl): abstract 6099.
- 13. Barton M, Gabriel GS, Shafiq J. Overview of cancer treatment services in Western Australia July 2008. Perth: Cancer Council Western Australia, 2008. http://www.cancerwa.asn.au/resources/Overview_of_cancer_treatment_services_in_Western_Australia.pdf (accessed Dec 2011).
- 14. Morgan G, Wigg D, Childs J. Projected requirements for radiation oncologists and trainees in Australia and New Zealand to 2007. Australas Radiol 2000; 44: 88-97.
- 15. Chiarella M, Duffield C. Workforce issues in palliative and end-of-life care. J Hosp Palliat Nurs 2007; 9: 334-341.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.